N@N

Market Maker Surveillance Report. ACMR, NVGN, OBCI, MSHL, HRZ, LTUS, Losing Stocks With Lowest Price Friction For Tuesday, Mar

March 29, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 2387 companies with "abnormal" market making, 3372 companies with positive Friction Factors and 2055 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. AC MOORE ARTS & CRAFTS INC (NASDAQ:ACMR), NOVOGEN LIMITED-SPONS ADR (NASDAQ:NVGN), OCEAN BIO-CHEM INC (NASDAQ:OBCI), MARSHALL EDWARDS INC (NASDAQ:MSHL), HORIZON LINES INC-CL A (NYSE:HRZ), LOTUS PHARMACEUTICALS INC (OTCBB:LTUS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     ACMR       $-0.570      -17.81%      251,929         23.71%       285,103         26.83%       -33,174         -582    
     NVGN       $-0.420      -19.35%      535,029         42.85%       710,717         56.92%       -175,688        -4,183  
     OBCI       $-0.640      -19.75%      151,709         42.99%       183,037         51.86%       -31,328         -490    
     MSHL       $-0.310      -15.27%      70,436          37.91%       114,243         61.49%       -43,807         -1,413  
     HRZ        $-1.320      -42.70%      3,522,906       44.71%       4,321,857       54.85%       -798,951        -6,053  
     LTUS       $-0.290      -18.35%      129,803         34.70%       131,089         35.04%       -1,286          -44     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows ACMR with a dollar loss Tuesday of $-0.57000 and a Friction Factor of -582 shares. That means that it only took 582 more shares of selling than buying to move ACMR lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

AC MOORE ARTS & CRAFTS INC (NASDAQ:ACMR) - A.C. Moore Arts & Crafts, Inc. operates as a specialty retailer of arts, crafts, and floral merchandise in the eastern region of the United States. Its stores offer art and scrapbooking items, traditional and fashion crafts, floral and floral accessories, home decor and frames, and seasonal items for children and adults. The company also offers its products through its Web site, acmoore.com. As of January 2, 2010, it operated 135 stores. The company was founded in 1984 and is based in Berlin, New Jersey.

NOVOGEN LIMITED-SPONS ADR (NASDAQ:NVGN) - Novogen Limited and its subsidiaries engage in the research and development of pharmaceutical products, and marketing of consumer healthcare products. The companys consumer healthcare products comprise Promensil, a range of natural products specifically for womens health; Vinalac, a probiotic formula to help prevent childhood allergies, such as eczema in children at risk of an allergy; Aliten for weight control; and Trinovin, for the enhancement and maintenance of mens health. It focuses on oncology, cardiovascular, dermatological, and anti-inflammatory programs. The companys programs include Phenoxodiol, a phase III investigational drug for late stage, chemoresistant ovarian cancer and prostate, and cervical cancers; Triphendiol, a phase I signal transduction inhibitor for the treatment of cholangiocarcinoma or bile duct cancer, and stage IIB through stage IV malignant melanoma; NV-128, a pre-clinical stage cancer compound to promote cancer cell death in multidrug resistant ovarian cancer cells by targeting the AKT-mTOR pathway; and GLYC-101, a phase II product for the treatment of wounds following laser ablation, burn wounds, surgical wounds, venous ulcers, and diabetic ulcers. Novogens programs also include NV-143, a derivative of triphendiol and a pan acting ant-cancer; NV-04, a program for cardiovascular disease; NV-27, an oral agent to prevent arterial restenosis following coronary artery angioplasty; and NV-07 for the protection of mice against UV-induced inflammatory changes in the skin and against UV-induced skin immune suppression. In addition, it develops NV-52 for the treatment of inflammatory bowel disease; and FAIMs, flavonoid anti-inflammatory molecules to avoid cardiovascular, gastrointestinal, and renal side effects associated with anti-inflammatory drugs. Novogen Limited offers its products in Australia, North America, and Europe. The company was founded in 1994 and is headquartered in North Ryde, Australia.

OCEAN BIO-CHEM INC (NASDAQ:OBCI) - Ocean Bio-Chem, Inc. engages in the manufacture, marketing, and distribution of various appearance and maintenance products for boats, recreational vehicles, automobiles, and aircrafts under the Star brite brand name, as well as private label formulations in the United States and Canada. The companys marine product line consists of polishes, cleaners, protectants, and waxes of various formulations. This line also includes motor oils, vinyl protectants, cleaners, teak cleaners, teak oils, bilge cleaners, hull cleaners, silicone sealants, polyurethane sealants, polysulfide sealants, gasket materials, lubricants, antifouling additives, and anti-freeze coolants, as well as brushes, poles and tie-downs, and other related marine accessories. Its automotive product line comprises hydraulic, gear, and motor oils; anti-freeze and windshield washes; and automotive polishes, cleaners, and associated appearance items. Ocean Bio-Chem also offers cleaners, polishes, detergents, fabric cleaners and protectors, silicone sealants, water proofers, gasket materials, degreasers, vinyl cleaners, protectors, toilet treatment fluids, and anti-freeze coolants to the recreational vehicle/power sports markets. In addition, it blends and packages various chemical formulations, as well as manufactures PVC and HDPE blow molded bottles. Further, the company offers StarTron enzyme fuel treatment for diesel and gas engines, as well as for the recreational vehicles, including snow mobiles, ATVs, and motorcycles. Ocean Bio-Chem sells its products to retailers and distributors. The company was formerly known as Star brite Corporation and changed its name to Ocean Bio-Chem, Inc. in 1984. Ocean Bio-Chem, Inc. was founded in 1973 and is based in Fort Lauderdale, Florida.

MARSHALL EDWARDS INC (NASDAQ:MSHL) - Marshall Edwards, Inc., a developmental stage pharmaceutical company, engages in the development and commercialization of drugs for the treatment of cancer in the United States and Australia. The company involves in the clinical development and commercialization of its phenoxodiol drug candidates for the treatment of cancer; triphendiol, a signal transduction inhibitor for the treatment of pancreas and bile duct cancers, and melanoma; NV-143, an investigational anti-cancer drug to sensitize melanoma cell lines to the standard of care drug, dacarbazine, and members of the platinum drug family; and NV-128, an investigational cancer compound to promote cancer cell death by targeting the specific protein regulatory pathway in ovarian cancer cells. It is also conducting a Phase II prostate cancer clinical trial using phenoxodiol. The company was founded in 2000 and is based in North Ryde, Australia. Marshall Edwards, Inc. is a subsidiary of Novogen Limited.

HORIZON LINES INC-CL A (NYSE:HRZ) - Horizon Lines, Inc., through its subsidiaries, provides container shipping and integrated logistics services. It ships a range of consumer and industrial items, such as refrigerated and non-refrigerated foodstuffs, household goods, auto parts, building materials, and other materials used in manufacturing. The company offers container shipping services to ports within the continental United States, Puerto Rico, Alaska, Hawaii, Guam, the U.S. Virgin Islands, and Micronesia. Its integrated logistics services comprise rail, truck brokerage, warehousing, distribution, expedited logistics, and non-vessel operating common carrier operations. Horizon Lines, Inc. also offers terminal services. The company operates terminals in Alaska, Hawaii, and Puerto Rico; contracts for terminal services in seven ports in the continental United States; and the ports in Guam, Yantian, and Xiamen, China, as well as Kaohsiung, Taiwan. In addition, it offers inland transportation services. As of December 20, 2009, the company owned or leased approximately 20 vessels and 18,500 cargo containers. Horizon Lines, Inc. serves consumer and industrial products companies, as well as various agencies of the U.S. government, including the Department of Defense and the U.S. Postal Service. The company was founded in 1956 and is based in Charlotte, North Carolina.

LOTUS PHARMACEUTICALS INC (OTCBB:LTUS) - Lotus Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceuticals in the Peoples Republic of China. The company markets valsartan capsules under the Maixin name to treat hypertension; eye drops under the Muxin name to treat glaucoma; and Octreotide Acetate Injection solution under the Yipubishan name for treating gastric ulcers. It also offers Junxin branded Levofloxacin, an anti-bacterial drug to treat mild, moderate, and severe infections caused by susceptible trains of acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, and acute pyelonephritis, as well as complicated and uncomplicated skin and skin structure infections, and urinary tract infections; and Nicergoline for Injection, an a-receptor blockage nerve system blood-brain medicine. The companys product pipeline under the pending SFDA approval status includes Isosorbide Mononitrate-sustained release tablets to prevent angina; Gliclazide-controlled release tablets to control hyperglycemia; and Laevo-Bambutero to treat acute and chronic asthma. Its development stage products comprise Total Hawthorn Flavonoids-sustained release tablets to control high blood pressure; and controlled release tablets, such as Doxazosin for curing benign prostatic hyperplasia, Nifedipine for curing hypertension and angina, Lovastatin for treating hypolipidemic, Simvastatin to treat hypolipidemic, Verapamil Hydrochloride for curing variant angina and unstable angina, and Valsartan for curing high blood pressure. The company also involves in retailing Western and traditional Chinese medications, and medical treatment equipment through retail locations; the research and development, and lab testing projects for third parties; leasing space to retail merchants and licensed medical practitioners; advertising; and the sale of developed drug formulas. As of December 31, 2009, it operated 10 drug stores. The company is based in Beijing, the Peoples Republic of China.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net